- Home
- KIDS vs CION Comparison
KIDS vs CION Comparison
Compare KIDS & CION Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KIDS | CION |
|---|---|---|
| Founded | 2007 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 524.3M | 527.0M |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | KIDS | CION |
|---|---|---|
| Price | $17.10 | $9.68 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 8 | 1 |
| Target Price | ★ $24.75 | $8.50 |
| AVG Volume (30 Days) | 226.5K | ★ 390.8K |
| Earning Date | 10-28-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 15.39% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.49 |
| Revenue | $227,410,000.00 | ★ $244,923,000.00 |
| Revenue This Year | $16.58 | N/A |
| Revenue Next Year | $12.46 | N/A |
| P/E Ratio | ★ N/A | $19.68 |
| Revenue Growth | ★ 19.90 | N/A |
| 52 Week Low | $15.28 | $8.51 |
| 52 Week High | $27.60 | $12.71 |
Technical Indicators
Market Signals| Indicator | KIDS | CION |
|---|---|---|
| Relative Strength Index (RSI) | 43.05 | 43.12 |
| Support Level | $17.18 | $9.89 |
| Resistance Level | $18.36 | $10.17 |
| Average True Range (ATR) | 0.72 | 0.20 |
| MACD | -0.13 | -0.04 |
| Stochastic Oscillator | 7.60 | 2.89 |
Price Performance
Historical ComparisonAbout KIDS OrthoPediatrics Corp.
OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercialize implants and instruments to meet the needs of surgeons and patients. Its products, include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia and ACL Reconstruction System among others.
About CION CION Investment Corporation
CION Invt Corp is an externally managed, non-diversified, closed-end management investment company that has elected to be regulated as a business development company. The Company's portfolio is comprised of investments in senior secured debt, including first lien loans, second lien loans, and unitranche loans, and, to a lesser extent, collateralized securities, structured products and other similar securities, unsecured debt, and equity, of private and thinly-traded U.S. middle-market companies. Its investment objective is to generate current income and, to a lesser extent, capital appreciation for investors.